| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -241.07M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MLYS returned +72.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -29.3% |
| 1 year | +72.3% |
| All-time high | $43.12 (Nov 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MLYS would be worth today ›No. Mineralys Therapeutics, Inc. has not paid a dividend in the past 12 months.
Mineralys Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol MLYS.
Mineralys Therapeutics, Inc. is part of the Healthcare sector.
Mineralys Therapeutics, Inc. has a market cap of 2.27B USD, based on the latest quote.
Mineralys Therapeutics, Inc. is expected to report earnings around Nov 10, 2026. That date is an estimate and has not been confirmed by the company.
